Replies to post #419 on Armata Pharmaceuticals, Inc. (ARMP)

[Rogerthat1]

Good to know. They're waiting for two more patients to enroll in the rhinosinusitis trial. Mostly they'll be in cohort 3 so 14 days of dosing seems like. Full data coming later this year.

Full data for phase 1 Army trial also coming later this year.

Anybody know more specific timelines here for both data releases? Looks like strong catalyst in last quarter 2016 imo.